Markii u dambaysay ee la cusboonaysiiyay Sebtember 8-deedii, 2022 saacadu markay ahayd 09:16 subaxnimo
Liiska ugu sareeya Swiss ku salaysan Shirkadaha Daawada kuwaas oo lagu saleeyay wadarta Dakhliga sanadka dambe. Roche waa kan ugu weyn Shirkadda Daawada Dalka Switzerland oo Dakhli dhan 66 Bilyan oo Doollarka Maraykanka ah soo galay sannadkii u dambeeyay waxa ku xiga Novartis iyo Vifor.
Roche - ugu weyn Shirkadda farmashiyaha gudaha Swiss: Intii lagu jiray 125-kii sano ee taariikhda, Roche waxay ku kortay mid ka mid ah shirkadaha bayoolajiga adduunka ee ugu weyn, iyo sidoo kale bixiyeyaasha hormuudka ah ee ogaanshaha in-vitro iyo bixiyaha caalamiga ah ee xalalka cusub ee isbeddelka ah ee dhammaan meelaha cudurrada waaweyn.
Liiska Shirkadaha Farmashiyeedka Ku Salaysan ee Swiss-ka ugu sarreeya
Haddaba halkan waa liiska ugu sarreeya Swiss Based Pharmaceutical Shirkadaha wadarta Iibka (Dakhliga).
| S.NO | Description | Wadarta Dakhliga | Shaqaalaha | Deynta Saamiga Sinnaanta | Ku soo noqo sinaanta | Astaanta Hantida |
| 1 | DHAGAX | $65,980 Milyan | 101465 | 0.4 | 40.4 | RO |
| 2 | NOVARTIS | $51,668 Milyan | 105794 | 0.6 | 17.3 | NOVN |
| 3 | VIFOR | $1,930 Milyan | 2600 | 0.2 | 5.9 | VIFN |
| 4 | SIEGFREED | $956 Milyan | 2500 | 0.9 | 13.9 | SFZN |
| 5 | BACHEM | $455 Milyan | 1529 | 0.3 | 21.3 | BANB |
| 6 | BASILEA | $144 Milyan | 150 | -2.9 | BSLN | |
| 7 | IDOORSIA | $81 Milyan | 5.5 | -237.9 | IDEA | |
| 8 | COSMO PHARM | $74 Milyan | 265 | 0.5 | -2.8 | COPN |
| 9 | SANTHERA | $17 Milyan | 91 | 5.2 | -1316.2 | SANN |
| 10 | SPEXIS N | $16 Milyan | 52 | -1.6 | -347.9 | SPEX |
| 11 | EVOLVA N | $9 Milyan | 65 | 0.1 | -29.1 | Xaawa |
| 12 | NEWRON PHARMA N | $6 Milyan | 3.1 | -110.5 | NWRN | |
| 13 | ADEX N | $4 Milyan | 27 | 0.0 | -89.8 | ADXN |
Novartis - Shirkadda labaad ee ugu weyn Swiss Pharma
Novartis waxaa la abuuray 1996 iyada oo loo marayo isku darka Ciba-Geigy iyo Sandoz. Novartis iyo shirkadihii ka horreeyay waxay raadraaceen xididdada in ka badan 250 sano, oo leh taariikh qani ah oo soo saarista alaabada cusub.
Novartis waxa ay dib u male-awaalaysaa daawada si ay u horumariso oo u kordhiso nolosha dadka. Maadaama ay tahay shirkad hormuud ka ah dawooyinka caalamiga ah, shirkaddu waxay adeegsataa saynis hal-abuur leh iyo tignoolajiyada dhijitaalka ah si ay u abuurto daawaynta beddelka meelaha baahiyaha caafimaad ee weyni ka jiro. Baadigoobkayaga helitaanka dawooyin cusub, shirkaddu waxay si joogto ah ugu jirtaa kaalinta koowaad ee adduunka shirkadaha ugu sareeya maalgelinta cilmi-baarista iyo horumarinta.
Alaabooyinka Novartis waxa ay gaadhaan ku dhawaad 800 milyan oo qof caalamka oo dhan waxaanan helnaa habab cusub oo lagu balaadhiyo helitaanka daawadii ugu dambaysay. Ilaa 110,000 oo qof oo in ka badan 140 jinsiyadood ayaa ka shaqeeya Novartis adduunka oo dhan.
Vifor Pharma
Vifor Pharma Group waa shirkad dawooyin ah oo caalami ah. Waxay higsaneysaa inay noqoto hogaamiyaha caalamiga ah ee yaraanta birta iyo nephrology iyada oo diiradda la saarayo cudurrada dhifka ah. Shirkaddu waa lamaanaha doorashada ee dawooyinka iyo xalalka diiradda saaraya bukaanka cusub.
Kooxda Vifor Pharma waxay ku dadaalaysaa inay ka caawiso bukaanada aduunka oo dhan qaba cudurada daran iyo kuwa dabadheeraada inay u horseedaan nolol ka wanaagsan, nolol caafimaad leh.
Bachem
Bachem waxaa la aasaasay 1971 by Peter Grogg sida Bachem Feinchemikalien AG oo leh laba shaqaale oo jooga Liestal oo u dhow Basel iyada oo diiradda la saarayo isku-dhafka peptide. Sanadkii 1977, Bachem wuxuu u guuray Bubendorf isagoo wata siddeed shaqaale ah wuxuuna 1978 soo saaray peptides si loogu isticmaalo daawada iyadoo la raacayo tilmaamaha GMP markii ugu horeysay. Intii u dhaxaysay 1981 iyo 1991, Bachem waxay laba jibaartay awoodeeda wax soo saar, halka tirada shaqaaluhu ay kordheen ilaa 150. 1995, xarumaha, oo ay ku jiraan waaxda ilaalinta tayada, ayaa la kordhiyay ilaa 168,000 sq. ft. (15,600 m2). Tirada shaqaaluhu waxay gaadhay 190.
Balaadhinta suuqyada aan Yurubta ahayn waxay ka bilaabantay aasaaskii Bachem Bioscience, Inc. ee Philadelphia, USA, 1987. Si loo xoojiyo joogitaankeeda Yurub, Bachem waxay furtay xarumaha iibka iyo suuqgeynta ee Jarmalka 1988 iyo in France 1993. 1996, waxay heshay soo saaraha labaad ee ugu weyn ee peptides, Bachem California ee Torrance, USA, oo ay la socdaan hoosaadyadeeda ee Germany iyo UK.
Bachem wuxuu soo baxay dadweynaha Juun 18, 1998. Saamiyada waxay ku qoran yihiin suuqa saamiyada Swiss. Kooxdu waxay ku guulaysatay iibka 96 milyan CHF waxayna shaqaalaysiisay 331 qof adduunka oo dhan. Sannadkii 1999, Bachem waxay heshay Peninsula Laboratories, Inc., oo xarunteedu tahay San Carlos, California, iyo kaabadeeda Ingiriiska, oo ku biirtay Bachem UK - lafteedu asal ahaan kabid ka mid ah Bachem Inc. ee fadhigeedu yahay California ee 2000.
Helitaanka Sochinaz SA, oo ah shirkad Swiss-ku salaysan (Vionnaz) oo ah soo saaraha takhasuska leh ee maaddooyinka dawooyinka firfircoon ee 2001, waxay xoojisay khibradda Bachem oo mar kale ballaarisay awooddeeda wax-soo-saarka. Tirakoobka kooxda ayaa wakhtigan koray ilaa 500 oo shaqaale, iibkuna waxa uu gaadhay 141,4 milyan CHF.
Marka ugu dambeyntii kuwani waa Liiska Shirkadaha Farmashiyeedka ee Swiss-ka ugu sarreeya ee ku saleysan iibka sannadkii dhawaa.
Wax badan ka akhri Shirkadaha ugu sarreeya ee Pharma ee Hindiya.
